Aussie Investors Fund Adult Stem Cell Research
Friday, July 28, 2006 - Stem Cell Guru
Australian institutions and wealthy investors yesterday found $15 million to fund continuing research into stem cell treatments for broken bones and cardio vascular diseases.
The research is undertaken by a Melbourne-based biotech which is already conducting human trials in Australia and is seeking United States Food and Drug Administration clearance for the therapy.
Research is aimed at isolating adult MPC cells, which have been found to generate new bone, cartilage and blood vessels. At Newcastle's John Hunter Hospital, a cardiovascular study is being conducted on patients who have suffered coronary artery disease resulting in heart attack and angina. Doctors at Royal Melbourne Hospital are presently trialling the stem cell treatment on orthopaedic cases, focusing on repairing large bone fractures which have failed to heal under conventional treatment.
The original article can be found at News.com.au
The research is undertaken by a Melbourne-based biotech which is already conducting human trials in Australia and is seeking United States Food and Drug Administration clearance for the therapy.
Research is aimed at isolating adult MPC cells, which have been found to generate new bone, cartilage and blood vessels. At Newcastle's John Hunter Hospital, a cardiovascular study is being conducted on patients who have suffered coronary artery disease resulting in heart attack and angina. Doctors at Royal Melbourne Hospital are presently trialling the stem cell treatment on orthopaedic cases, focusing on repairing large bone fractures which have failed to heal under conventional treatment.
The original article can be found at News.com.au
Site Feed
0 Comments:
Post a Comment
<< Home